Bridge to transplant with the HeartMate device.

Area of Science:

• Cardiology
• Medical Devices
• Transplantation Medicine

Background:

• Chronic heart failure incidence and prevalence are increasing globally.
• Cardiac transplantation is limited by donor organ scarcity, leading to prolonged waiting times.
• Mechanical circulatory support devices, like the HeartMate LVAD, have advanced significantly.

Purpose of the Study:

• To summarize the bridging experience with the HeartMate LVAD.
• To focus on the clinical experience with HeartMate LVAD at Rush-Presbyterian-St. Luke's Medical Center.
• To highlight the benefits of LVAD as a bridge to transplantation for refractory heart failure patients.

Main Methods:

• Review of the overall bridging experience with the HeartMate LVAD.
• Analysis of specific patient data and outcomes at Rush-Presbyterian-St. Luke's Medical Center.
• Evaluation of LVAD use in patients refractory to medical management.

Main Results:

• The HeartMate LVAD has demonstrated excellent results as a bridge to transplantation.
• LVAD support reliably sustains patients until a donor heart becomes available.
• Bridging with LVAD allows for correction of physiological and metabolic issues, improving patient condition pre-transplant.

Conclusions:

• The HeartMate LVAD is an effective therapy for patients with chronic heart failure awaiting transplantation.
• Early LVAD placement in refractory patients offers advantages in nutritional status, economics, and quality of life.
• The device provides reliable support, enabling better patient preparation for cardiac transplantation.